Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 185
Filtrar
Mais filtros








Intervalo de ano de publicação
2.
PLoS One ; 17(1): e0262358, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34986200

RESUMO

BACKGROUND: "Contracting Out" is a popular strategy to expand coverage and utilization of health services. Bangladesh began contracting out primary healthcare services to NGOs in urban areas through the Urban Primary Health Care Project (UPHCP) in 1998. Over the three phases of this project, retention of trained and skilled human resources, especially doctors, proved to be an intractable challenge. This paper highlights the issues influencing doctor's retention both in managerial as well as service provision level in the contracted-out setting. METHODOLOGY: In this qualitative study, 42 Key Informant Interviews were undertaken with individuals involved with UPHCP in various levels including relevant ministries, project personnel representing the City Corporations and municipalities, NGO managers and doctors. Verbatim transcripts were coded in ATLAS.ti and analyzed using the thematic analysis. Document review was done for data triangulation. RESULTS: The most cited problem was a low salary structure in contrast to public sector pay scale followed by a dearth of other financial incentives such as performance-based incentives, provident funds and gratuities. Lack of career ladder, for those in both managerial and service delivery roles, was also identified as a factor hindering staff retention. Other disincentives included inadequate opportunities for training to improve clinical skills, ineffective staffing arrangements, security issues during night shifts, abuse from community members in the context of critical patient management, and lack of job security after project completion. CONCLUSIONS: An adequate, efficient and dedicated health workforce is a pre-requisite for quality service provision and patient utilization of these services. Improved career development opportunities, the provision of salaries and incentives, and a safer working environment are necessary actions to retain and motivate those serving in managerial and service delivery positions in contracting out arrangements.


Assuntos
Mão de Obra em Saúde/legislação & jurisprudência , Médicos/legislação & jurisprudência , Atenção Primária à Saúde/legislação & jurisprudência , Bangladesh , Mobilidade Ocupacional , Humanos , Motivação , Políticas , Setor Público/legislação & jurisprudência , Pesquisa Qualitativa , Salários e Benefícios/legislação & jurisprudência , Recursos Humanos/legislação & jurisprudência
3.
J Law Med Ethics ; 49(1): 34-38, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33966648

RESUMO

A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public's investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.


Assuntos
Pesquisa Biomédica/economia , Desenvolvimento de Medicamentos/economia , Medicamentos Genéricos/economia , Financiamento Governamental/legislação & jurisprudência , Patentes como Assunto/legislação & jurisprudência , Monofosfato de Adenosina/análogos & derivados , Monofosfato de Adenosina/economia , Monofosfato de Adenosina/provisão & distribuição , Alanina/análogos & derivados , Alanina/economia , Alanina/provisão & distribuição , Setor Público/legislação & jurisprudência
5.
Subst Abuse Treat Prev Policy ; 15(1): 47, 2020 07 20.
Artigo em Inglês | MEDLINE | ID: mdl-32690036

RESUMO

BACKGROUND: The burden of substance use disorders in sub-Saharan Africa has been projected to increase by an estimated 130% by 2050. Despite this, little is known about the substance use disorder treatment and prevention systems in the region. OBJECTIVES: The objective of this review is to describe the public sector substance use disorder treatment and prevention systems in Kenya guided by the World Health Organization health systems framework model, with the aim of informing decision-making. METHODS: We reviewed official government documents obtained from hand-searching the websites of relevant governmental organizations including: Ministry of Health, National Authority for the Campaign Against Alcohol and Drug Abuse, Parliament of Kenya, Ministry of Treasury & National Planning, National Law Reporting Council, Kenya National Bureau of Statistics, the National Non-Governmental Organization (NGO) Coordination Board and the 47 County Governments. We augmented those searches with official documents that the authors were aware of by virtue of being practitioners in the field. Draft and retired documents were excluded. The findings of the search are presented as a narrative review. DISCUSSION: The Mental Health Act 1989, the main legislative framework governing substance use disorder treatment and prevention, focuses on institutional care only. While there are only three public health facilities offering substance use disorder treatment in Kenya, several non-public sector actors are involved in SUD treatment and prevention activities. Unfortunately, there is limited cross-sector collaboration. The Ministry of Health has no specific budget for substance use disorder treatment and prevention, while the National Authority for the Campaign Against Alcohol and Drug Abuse has an annual resource gap of about US$ 5,000,000. The substance use disorder workforce in Kenya has not been characterized. CONCLUSION: We propose five key strategies for strengthening substance use disorder treatment and prevention systems in Kenya including: (1) Enactment of the Mental Health (Amendment) bill 2018. (2) Integration of substance use disorder treatment and prevention into primary health care to increase access to care. (3) Utilization of money from taxation of alcohol, tobacco and betting to increase funding for substance use disorder treatment and prevention. (4) Characterization of the substance use disorder workforce to inform planning. (5) Enhanced collaboration between the government and non-state actors in order to increase access to SUD treatment and prevention.


Assuntos
Setor Público/estatística & dados numéricos , Centros de Tratamento de Abuso de Substâncias/provisão & distribuição , Transtornos Relacionados ao Uso de Substâncias/terapia , Comportamento Cooperativo , Política de Saúde , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Quênia , Atenção Primária à Saúde/organização & administração , Setor Privado/estatística & dados numéricos , Setor Público/legislação & jurisprudência , Transtornos Relacionados ao Uso de Substâncias/prevenção & controle
6.
JMIR Public Health Surveill ; 6(3): e20478, 2020 07 21.
Artigo em Inglês | MEDLINE | ID: mdl-32589151

RESUMO

In this viewpoint, we present public policies and public health strategies for a gradual lockdown lifting during the coronavirus disease (COVID-19) crisis in two country cases, Jordan and the United Arab Emirates. While managing pandemics is critical in terms of preparedness, response, and recovery, it is equally vital to ensure that the measures for a lockdown exit are both efficient and effective. It is critical to learn from first-wave lessons to systematize responses during times of crisis and execute appropriate public policies and public health strategies. This viewpoint highlights the importance of the following during lockdown lifting: pandemic control, health care capacity, training, scaling up of resources and systems, and priority setting of public policies by acknowledging challenges, developing policy insights, and setting the policy direction. The systematic approaches and leadership thinking required for lifting lockdowns during a crisis include the three Rs: Readiness, Responses, and Resilience & Recovery.


Assuntos
Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/prevenção & controle , Pandemias/prevenção & controle , Pneumonia Viral/epidemiologia , Pneumonia Viral/prevenção & controle , Saúde Pública/métodos , Política Pública , Setor Público/legislação & jurisprudência , COVID-19 , Humanos , Jordânia/epidemiologia , Emirados Árabes Unidos/epidemiologia
7.
Rev Saude Publica ; 54: 42, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32321058

RESUMO

OBJECTIVE: To describe students protected by laws and exposed to soft drinks sales and assess whether forbidding laws are associated with lower availability of these beverages. METHODS: We identified laws forbidding non-government administered cafeterias or sales of soft drinks in schools in the 27 Brazilian state capitals. Data on soft drinks sales were obtained from Pesquisa Nacional de Saúde do Escolar 2015 (PeNSE - National Survey of School Health 2015), for a representative sample of 9th graders from public and private schools. Students were attributed with the status of their school regarding the law and sale of soft drinks. Co-variables were school status (public or private), school size, geographic regions, mother's educational level, score of goods and services. We performed multivariate analyses using Poisson regression. RESULTS: The total of 23 laws forbidding sales of soft drinks covered 63.0% of capitals, comprising 56.9% of students. Law coverage was higher among students from more developed regions (67.6%) and in public schools (60.6%), compared with those from less developed regions (38.0%) and private schools (45.8%). Soft drinks were available for 33.9% of students. Students attending public schools in less developed regions had the lowest availability of soft drinks, regardless of law coverage (14.8%; 12.0%); while students attending private schools in these regions had a high availability, regardless of law coverage (82.1%; 73.4%). Restrictive laws were associated with lower sales of soft drinks in more developed regions, and restrictions had a greater association with the availability of soft drinks in public schools (PR = 0.25; 95%CI = 0.15-0.41), compared with private schools (PR = 0.48; 95%CI = 0.35-0.66). CONCLUSION: Laws restricting soft drinks in schools were associated with fewer sales in more developed regions. Private schools were less compliant with the law than public schools. A broadly enforced national law could reduce the availability of soft drinks in schools.


Assuntos
Bebidas Gaseificadas/legislação & jurisprudência , Comércio/legislação & jurisprudência , Instituições Acadêmicas/legislação & jurisprudência , Brasil , Fidelidade a Diretrizes/estatística & dados numéricos , Humanos , Setor Privado/legislação & jurisprudência , Setor Público/legislação & jurisprudência , Instituições Acadêmicas/estatística & dados numéricos , Estudantes/estatística & dados numéricos , Inquéritos e Questionários
8.
Sci Eng Ethics ; 26(1): 1-25, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31123979

RESUMO

Stem cell technology is an emerging science field; it is the unique regenerative ability of the pluripotent stem cell which scientists hope would be effective in treating various medical conditions. While it has gained significant advances in research, it is a sensitive subject involving human embryo destruction and human experimentation, which compel governments worldwide to ensure that the related procedures and experiments are conducted ethically. Based on face-to-face interviews with selected Malaysian ethicists, scientists and policymakers, the objectives and effectiveness of the current Guideline for Stem Cell Research and Therapy (2009) are examined. The study's findings show that the guideline is rather ineffective in ensuring good ethical governance of the technology. A greater extent of unethical conduct is likely present in the private medical clinics or laboratories offering stem cell therapies compared with the public medical institutions providing similar services, as the latter are closely monitored by the governmental agencies enforcing the relevant policies and laws. To address concerns over malpractices or unethical conduct, this paper recommends a comprehensive revision of the current stem cell guideline so that adequate provisions exist to regulate the explicit practices of the private and public stem cell sectors, including false advertising and accountability. The newly revised Malaysian stem cell guideline will align with the Guidelines for Stem Cell Research and Clinical Translation (2016) of the International Society for Stem Cell Research (ISSCR) containing secular but universal moral rules. However, a regulatory policy formulated to govern the technology remains the main thrust of empowering the guideline for compliance among the stakeholders.


Assuntos
Guias como Assunto , Políticas , Pesquisa com Células-Tronco/ética , Pesquisa com Células-Tronco/legislação & jurisprudência , Tecnologia Biomédica/ética , Tecnologia Biomédica/legislação & jurisprudência , Humanos , Malásia , Turismo Médico , Setor Privado/ética , Setor Privado/legislação & jurisprudência , Má Conduta Profissional , Setor Público/ética , Setor Público/legislação & jurisprudência , Religião e Ciência
9.
Rev. saúde pública (Online) ; 54: 42, 2020. tab, graf
Artigo em Inglês | LILACS, BBO - Odontologia | ID: biblio-1101857

RESUMO

ABSTRACT OBJECTIVE To describe students protected by laws and exposed to soft drinks sales and assess whether forbidding laws are associated with lower availability of these beverages. METHODS We identified laws forbidding non-government administered cafeterias or sales of soft drinks in schools in the 27 Brazilian state capitals. Data on soft drinks sales were obtained from Pesquisa Nacional de Saúde do Escolar 2015 (PeNSE - National Survey of School Health 2015), for a representative sample of 9th graders from public and private schools. Students were attributed with the status of their school regarding the law and sale of soft drinks. Co-variables were school status (public or private), school size, geographic regions, mother's educational level, score of goods and services. We performed multivariate analyses using Poisson regression. RESULTS The total of 23 laws forbidding sales of soft drinks covered 63.0% of capitals, comprising 56.9% of students. Law coverage was higher among students from more developed regions (67.6%) and in public schools (60.6%), compared with those from less developed regions (38.0%) and private schools (45.8%). Soft drinks were available for 33.9% of students. Students attending public schools in less developed regions had the lowest availability of soft drinks, regardless of law coverage (14.8%; 12.0%); while students attending private schools in these regions had a high availability, regardless of law coverage (82.1%; 73.4%). Restrictive laws were associated with lower sales of soft drinks in more developed regions, and restrictions had a greater association with the availability of soft drinks in public schools (PR = 0.25; 95%CI = 0.15-0.41), compared with private schools (PR = 0.48; 95%CI = 0.35-0.66). CONCLUSION Laws restricting soft drinks in schools were associated with fewer sales in more developed regions. Private schools were less compliant with the law than public schools. A broadly enforced national law could reduce the availability of soft drinks in schools.


Assuntos
Humanos , Instituições Acadêmicas/legislação & jurisprudência , Bebidas Gaseificadas , Comércio/legislação & jurisprudência , Instituições Acadêmicas/estatística & dados numéricos , Estudantes/estatística & dados numéricos , Brasil , Inquéritos e Questionários , Setor Público/legislação & jurisprudência , Setor Privado/legislação & jurisprudência , Fidelidade a Diretrizes/estatística & dados numéricos
10.
Rev Saude Publica ; 53: 58, 2019 Jul 18.
Artigo em Inglês, Português | MEDLINE | ID: mdl-31340350

RESUMO

To advance in order to overcome the challenge of enabling greater autonomy in the use of financial resources in the Unified Health System (SUS), system managers agreed that transfers from the Union to other federated entities will be carried out through a financial investment account and a costing account. Over the past few years, states and municipalities managed more than 34,000 bank accounts dedicated to the Union's on-lendings, in which balance exceeded R$8 billion. However, from 2018, Ordinance 3,992/2017 unequivocally separated the budget flow from the financial flow, and the fund-to-fund transfers started to be carried out in only 11,190 bank accounts. Since then, managers have had financial autonomy in the management of financial resources received from the Union, if in accordance with the parameters established in their respective budget items at the end of each fiscal year.


Assuntos
Orçamentos/legislação & jurisprudência , Orçamentos/organização & administração , Gastos em Saúde/legislação & jurisprudência , Programas Nacionais de Saúde/economia , Programas Nacionais de Saúde/legislação & jurisprudência , Brasil , Orçamentos/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Humanos , Programas Nacionais de Saúde/organização & administração , Setor Público/economia , Setor Público/legislação & jurisprudência , Setor Público/organização & administração
11.
Rev. saúde pública (Online) ; 53: 58, jan. 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1014534

RESUMO

ABSTRACT To advance in order to overcome the challenge of enabling greater autonomy in the use of financial resources in the Unified Health System (SUS), system managers agreed that transfers from the Union to other federated entities will be carried out through a financial investment account and a costing account. Over the past few years, states and municipalities managed more than 34,000 bank accounts dedicated to the Union's on-lendings, in which balance exceeded R$8 billion. However, from 2018, Ordinance 3,992/2017 unequivocally separated the budget flow from the financial flow, and the fund-to-fund transfers started to be carried out in only 11,190 bank accounts. Since then, managers have had financial autonomy in the management of financial resources received from the Union, if in accordance with the parameters established in their respective budget items at the end of each fiscal year.


RESUMO A fim de avançar na superação do desafio de viabilizar maior autonomia na utilização dos recursos financeiros no Sistema Único de Saúde, os gestores do sistema pactuaram que as transferências da União aos demais entes federados passam a ser realizadas por meio de uma conta financeira de investimento e uma conta de custeio. Ao longo dos últimos anos, estados e municípios chegaram a gerenciar mais de 34 mil contas bancárias dedicadas somente aos repasses da União, nas quais foram acumulados saldos acima de R$8 bilhões. Entretanto, a partir de 2018, a Portaria 3.992/2017 separou de forma inequívoca o fluxo orçamentário do fluxo financeiro e as transferências fundo a fundo passaram a ser realizadas em apenas 11.190 contas bancárias. Desde então, os gestores passaram a ter autonomia financeira na gestão dos recursos financeiros recebidos da União, desde que obedecidos os parâmetros estabelecidos em suas respectivas peças orçamentárias ao final de cada exercício.


Assuntos
Humanos , Orçamentos/legislação & jurisprudência , Orçamentos/organização & administração , Gastos em Saúde/legislação & jurisprudência , Programas Nacionais de Saúde/economia , Programas Nacionais de Saúde/legislação & jurisprudência , Brasil , Orçamentos/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Setor Público/economia , Setor Público/legislação & jurisprudência , Setor Público/organização & administração , Programas Nacionais de Saúde/organização & administração
12.
Contraception ; 99(3): 160-164, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30502328

RESUMO

OBJECTIVES: In the Mexico City Metropolitan Area, only women in the city center have local access to legal first-trimester abortion. We quantify how this legislative discrepancy affects access to legal, public-sector abortion across the metropolitan area. STUDY DESIGN: In this observational study, we used a dataset representing 67.2% of all abortions occurring between 2010 and 2012 in Mexico City's public abortion program and census population data. We calculate utilization rates for 75 municipalities in the metropolitan area for 2010-2012. We compare utilization between municipalities with and without local legal access, adjusting for differences in sociodemographic drivers of abortion demand. We explore the effects of local abortion legality, travel time and socioeconomic status (SES). RESULTS: Women who had to travel into the city center for legal abortions used services at only 18.6% (95% CI 13.3%-33.0%) of the expected rate if they had local access, adjusting for sociodemographic factors. After controlling for travel time and SES, women who lived where abortion is illegal had a 58.6% (95% CI 21.5%-78.1%) reduction in access, and each additional 15 min of travel further reduced access by 33.7% (95% CI 18.2%-46.3%). Women who travel to seek legal abortions are more likely to have completed secondary education compared to other reproductive age women in their municipality (p = <.00001). CONCLUSIONS: We find that, in the Mexico City Metropolitan Area, both living where abortion is illegal and having to travel further to access services substantially reduce access to legal, public-sector abortion. These burdens disproportionately affect women of lower SES. IMPLICATIONS: Both local legality and proximate access are key to ensuring equity in access to public-sector abortion. Legalization of abortion services across the greater Mexico City Metropolitan Area has the potential to increase equity in utilization and meet unmet demand for legal abortion.


Assuntos
Aspirantes a Aborto , Aborto Legal/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Setor Público/legislação & jurisprudência , Adulto , Cidades , Feminino , Humanos , Prontuários Médicos , México , Gravidez , Análise de Regressão , Classe Social , Viagem , Adulto Jovem
14.
Philos Trans A Math Phys Eng Sci ; 376(2128)2018 Sep 13.
Artigo em Inglês | MEDLINE | ID: mdl-30082305

RESUMO

This article considers some of the risks and challenges raised by the use of algorithm-assisted decision-making and predictive tools by the public sector. Alongside, it reviews a number of long-standing English administrative law rules designed to regulate the discretionary power of the state. The principles of administrative law are concerned with human decisions involved in the exercise of state power and discretion, thus offering a promising avenue for the regulation of the growing number of algorithm-assisted decisions within the public sector. This article attempts to re-frame key rules for the new algorithmic environment and argues that 'old' law-interpreted for a new context-can help guide lawyers, scientists and public sector practitioners alike when considering the development and deployment of new algorithmic tools.This article is part of a discussion meeting issue 'The growing ubiquity of algorithms in society: implications, impacts and innovations'.


Assuntos
Algoritmos , Tomada de Decisões , Setor Público/legislação & jurisprudência , Setor Público/organização & administração , Probabilidade
15.
Trials ; 19(1): 267, 2018 May 03.
Artigo em Inglês | MEDLINE | ID: mdl-29724229

RESUMO

BACKGROUND: Randomized clinical trials that have public health implications but no or low potential for commercial gain are predominantly funded by governmental (e.g., National Institutes of Health (NIH)) and not-for-profit organizations. Our objective was to develop an alternative clinical trial site funding model for judicious allocation of declining public research funds. METHODS: In the Vitamin D and Type 2 Diabetes (D2d) study, an NIH-supported, large clinical trial testing the effect of vitamin D supplementation on incident diabetes in 2423 participants at high risk for diabetes, a hybrid financial management model for supporting collaborating clinical sites was developed and applied. The funding model employed two reimbursement components: Core (for study start-up and partial efforts throughout the study, ~40% of the total site budget), invoiced by sites, and Performance-Based Payments (for successful enrollment of participants and completion of follow-up visits, ~60% of the total site budget), automatically issued to the sites by the Coordinating Center based on actual recruitment and visits conducted. Underperforming sites transitioned to Performance-Based Payments only. RESULTS: Recruitment occurred from October 2013 through December 2016, requiring one additional year than the 2-year projection. Median enrollment at each site was 88 participants (range 29-318; 20 to 205% of the site target). At the end of year 1, study-wide recruitment was at 12% of the target (vs. 50% projected) and 12% of the total grant award was invested. The model constantly evaluated sites' needs and re-allocated resources to meet the study enrollment goal. If D2d had issued cost reimbursement subaward agreements and sites invoiced for their entire budget, 83% of the award would have been spent for all study activities over the first 4 years of the trial compared to 65% of the award spent (US$26M) under the hybrid model used by D2d. CONCLUSIONS: It is feasible to foster a hybrid financial management approach to steward limited available public funds for research in a dynamic and consistent way that does not compromise the trial's scientific integrity and ensures conservation of funds to complete recruitment and continue to follow up participants.


Assuntos
Colecalciferol/administração & dosagem , Diabetes Mellitus Tipo 2/prevenção & controle , Suplementos Nutricionais , Financiamento Governamental/economia , Estudos Multicêntricos como Assunto/economia , National Institutes of Health (U.S.)/economia , Setor Público/economia , Ensaios Clínicos Controlados Aleatórios como Assunto/economia , Orçamentos , Colecalciferol/efeitos adversos , Colecalciferol/economia , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/economia , Diabetes Mellitus Tipo 2/epidemiologia , Suplementos Nutricionais/efeitos adversos , Suplementos Nutricionais/economia , Financiamento Governamental/legislação & jurisprudência , Regulamentação Governamental , Custos de Cuidados de Saúde , Humanos , Incidência , Modelos Econômicos , Estudos Multicêntricos como Assunto/legislação & jurisprudência , National Institutes of Health (U.S.)/legislação & jurisprudência , Seleção de Pacientes , Setor Público/legislação & jurisprudência , Ensaios Clínicos Controlados Aleatórios como Assunto/legislação & jurisprudência , Mecanismo de Reembolso , Fatores de Tempo , Resultado do Tratamento , Estados Unidos/epidemiologia
16.
Artigo em Alemão | MEDLINE | ID: mdl-29209759

RESUMO

Through the years, a range of privately funded medical training opportunities has been established in Germany. Only a few of them operate along the German Medical Licensure Act and thus underlie quality assurance regulations in Germany. Most of the courses are a result of German hospitals cooperating with universities from other EU countries. The content of the courses and the examinations underlie the regulations of the university's home country. This article aims to give an overview of the private medical training opportunities offered in Germany and to show differences compared to state funded German medical schools. The authors discuss the opportunities of private medical training as well as its challenges and risks. Basic principles concerning finances and quality assurance of national and international private medical training are provided. Regardless of their mode of financing, the superior goal of the training, according to the German Medical Licensure Act, should always be to enable young doctors to pursue further professional training, so that they can maintain the best possible quality in patient care, research, and medical education.


Assuntos
Competência Clínica/legislação & jurisprudência , Educação Médica/legislação & jurisprudência , Licenciamento em Medicina/legislação & jurisprudência , Setor Privado/legislação & jurisprudência , Garantia da Qualidade dos Cuidados de Saúde/legislação & jurisprudência , Competência Clínica/normas , Currículo/normas , Educação Médica/normas , Educação Médica Continuada/legislação & jurisprudência , Educação Médica Continuada/normas , Educação de Pós-Graduação em Medicina/legislação & jurisprudência , Educação de Pós-Graduação em Medicina/normas , Alemanha , Humanos , Licenciamento em Medicina/normas , Setor Privado/normas , Setor Público/legislação & jurisprudência , Setor Público/normas , Garantia da Qualidade dos Cuidados de Saúde/normas , Faculdades de Medicina/legislação & jurisprudência , Faculdades de Medicina/normas
17.
Behav Sci Law ; 35(4): 303-318, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28612397

RESUMO

This article begins with the history of the rise and fall of the state hospitals and subsequent criminalization of persons with serious mental illness (SMI). Currently, there is a belief among many that incarceration has not been as successful as hoped in reducing crime and drug use, both for those with and those without SMI. Moreover, overcrowding in correctional facilities has become a serious problem necessitating a solution. Consequently, persons with SMI in the criminal justice system are now being released in large numbers to the community and hopefully treated by public sector mental health. The issues to consider when releasing incarcerated persons with SMI into the community are as follows: diversion and mental health courts; the expectation that the mental health system will assume responsibility; providing asylum and sanctuary; the capabilities, limitations, and realistic treatment goals of community outpatient psychiatric treatment for offenders with SMI; the need for structure; the use of involuntary commitments, including assisted outpatient treatment, conservatorship and guardianship; liaison between treatment and criminal justice personnel; appropriately structured, monitored, and supportive housing; management of violence; and 24-hour structured in-patient care. Copyright © 2017 John Wiley & Sons, Ltd.


Assuntos
Direito Penal/métodos , Criminosos/psicologia , Transtornos Mentais/terapia , Assistência Ambulatorial/tendências , Internação Compulsória de Doente Mental , Crime/psicologia , Direito Penal/história , História do Século XX , História do Século XXI , Hospitais Psiquiátricos/ética , Hospitais Psiquiátricos/história , Hospitais Psiquiátricos/legislação & jurisprudência , Humanos , Transtornos Mentais/psicologia , Transtornos Mentais/reabilitação , Saúde Mental/história , Saúde Mental/legislação & jurisprudência , Setor Público/história , Setor Público/legislação & jurisprudência , Estados Unidos , Violência/psicologia
18.
J Pak Med Assoc ; 67(1): 37-41, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28065952

RESUMO

OBJECTIVE: To investigate the efficacy and impact of Protection Against Harassment of Women at Workplace Act 2010 in the public health sector in its socio-legal perspective. METHODS: This cross-sectional study was conducted from July to December 2014 in Abbottabad, Pakistan, and comprised subjects selected from 53 basic health units managed by the government. SPSS 20 was used for statistical analysis. RESULTS: Of the 450 questionnaires, 430(96.6%) were returned duly filled. Overall, 40% male (120 respondents) and 26% female (34 respondents) knew about the Act. Besides, 39% males (117 respondents) and 63% females (82 respondents) appeared unsatisfied with the complaint mechanism prescribed in the Act; all the respondents established that no case had been registered after the introduction of the Act. Overall, 31% males (93 respondents) and 57% females (74 respondents) thought that without the health governance commitment and social support structure the Act could not work. CONCLUSIONS: The Protection Against Harassment of Women at Workplace Act 2010 was considered ineffective by the respondents who were concerned about the lack of social support system for the Act.


Assuntos
Pessoal de Saúde/estatística & dados numéricos , Setor Público/legislação & jurisprudência , Assédio Sexual , Mulheres Trabalhadoras/legislação & jurisprudência , Local de Trabalho/legislação & jurisprudência , Estudos Transversais , Feminino , Humanos , Masculino , Paquistão , Administração em Saúde Pública/legislação & jurisprudência , Assédio Sexual/legislação & jurisprudência , Assédio Sexual/prevenção & controle
19.
PLoS One ; 11(3): e0152020, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27002977

RESUMO

BACKGROUND: Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries. AIMS: To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies. MATERIALS AND METHODS: Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing. RESULTS: Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of ≥20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys. CONCLUSIONS: Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries.


Assuntos
Antibacterianos/uso terapêutico , Medicamentos Essenciais/uso terapêutico , Prescrição Inadequada/legislação & jurisprudência , Infecções Respiratórias/tratamento farmacológico , Prescrições de Medicamentos/normas , Resistência Microbiana a Medicamentos/efeitos dos fármacos , Humanos , Políticas , Setor Público/legislação & jurisprudência , Organização Mundial da Saúde
20.
J Agric Food Chem ; 64(2): 394-402, 2016 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-26751159

RESUMO

Advances in biotechnology continue to drive the development of a wide range of insect-protected, herbicide-tolerant, stress-tolerant, and nutritionally enhanced genetically modified (GM) crops, yet societal and public policy considerations may slow their commercialization. Such restrictions may disproportionately affect developing countries, as well as smaller entrepreneurial and public sector initiatives. The 2014 IUPAC International Congress of Pesticide Chemistry (San Francisco, CA, USA; August 2014) included a symposium on "Challenges Associated with Global Adoption of Agricultural Biotechnology" to review current obstacles in promoting GM crops. Challenges identified by symposium presenters included (i) poor public understanding of GM technology and the need for enhanced communication strategies, (ii) nonharmonized and prescriptive regulatory requirements, and (iii) limited experience with regulations and product development within some public sector programs. The need for holistic resistance management programs to enable the most effective use of insect-protected crops was also a point of emphasis. This paper provides details on the symposium discussion and provides background information that can be used in support of further adoption of beneficial GM crops. Overall, it emphasizes that global adoption of modern agricultural biotechnology has not only provided benefits to growers and consumers but has great potential to provide solutions to an increasing global population and diminishing agricultural land. This potential will be realized by continued scientific innovation, harmonized regulatory systems, and broader communication of the benefits of the high-yielding, disease-resistant, and nutritionally enhanced crops attainable through modern biotechnology.


Assuntos
Produtos Agrícolas/normas , Alimentos Geneticamente Modificados/normas , Plantas Geneticamente Modificadas/química , Setor Público , Produtos Agrícolas/química , Produtos Agrícolas/genética , Inocuidade dos Alimentos , Humanos , Plantas Geneticamente Modificadas/genética , Setor Público/legislação & jurisprudência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA